Research and Collaboration Arrangements - Additional Information (Details) - Otsuka Pharmaceutical Co., Ltd - Collaboration and License Agreements - USD ($) $ in Millions |
1 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended |
|---|---|---|---|---|
Oct. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | ||||
| Upfront cash payment | $ 85.0 | $ 85.0 | ||
| Eligible potential milestone payments | $ 335.5 | |||
| Upfront payments received | $ 85.0 | |||
| Unsatisfied or partially unsatisfied performance obligations | $ 33.4 | $ 33.4 | ||
| Revenue from clinical trials and other studies performance obligations | 3.7 | 6.6 | ||
| Estimated cost sharing and reimbursement amount due | $ 4.6 | $ 4.6 |